American Society of Hematology
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation
Read the guideline
Abstract
Sickle cell disease (SCD) is a life-limiting inherited hemoglobinopathy that results in significant complications and affects quality of life. Hematopoietic stem cell transplantation (HSCT) is currently the only curative intervention for SCD; however, guidelines are needed to inform how to apply HSCT in clinical practice.
More in surgery
- American Society for Metabolic and Bariatric Surgery review of endobariatric proceduresAmerican Society for Metabolic and Bariatric Surgery · 2026
- Non-pneumatic compression and its clinical utility in management of lymphedema. A position statement endorsed by the American Venous Forum and the American Venous and Lymphatic SocietyAmerican Venous Forum and American Venous and Lymphatic Society · 2026
